Focus on heart failure and cardiomyopathies: new ESC Guidelines and key meta-analyses.

Eur Heart J 2023; 44: 3658 - 68. https://doi.org/10.1093/eurheartj/ehad346 Google Scholar OpenURL Placeholder Text WorldCat 13 Angermann CE, Ertl G. Remote heart failure management guided by pulmonary artery pressure home monitoring: rewriting the future? This commercially available technology uses a wireless implantable sensor powered externally by radiofrequency energy placed in a branch of the left pulmonary artery to transmit daily snapshot estimates of PAP to health-care providers, thus facilitating close remote patient management without the need for in-person visits, and timely dynamic adjustments of HF treatments as required. The SGLT2 inhibitors have established themselves as robust, disease-modifying therapies and as recent trial results are incorporated into clinical guidelines, will likely become foundational in the therapy of HFpEF. [Extracted from the article]